The efficacy and safety of a pharmacologic protocol for maintaining coronary artery bypass patients at a higher mean arterial pressure during cardiopulmonary bypass

Journal of Extra-Corporeal Technology

Volumn 30, Issue 2, 1998, Pages 64-72

  Pirraglia, Paul A ^a   Peterson, Janey C ^a   Hartman, Gregg S ^a   Yao, Fun Sun F ^a   Thomas, Stephen J ^a   Charlson, Mary E ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass surgery; Mean arterial pressure; Phenylephrine; Sodium nitroprusside

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; FENTANYL; GLYCERYL TRINITRATE; ISOPRENALINE; METARAMINOL; MIDAZOLAM; NITROPRUSSIDE SODIUM; NORADRENALIN; PANCURONIUM; PHENYLEPHRINE; THIOPENTAL;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTENSIVE CARE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0031868660     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass: a randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg. 1995; 110: 1302-14.
2. Hollenberg JP, Pirraglia PA, Williams-Russo P, et al. Computerized data collection in the operating room during coronary artery bypass graft surgery: a comparison to the handkept anesthesia record. J Cardiothorac Vase Anesth. 1997; 11 (5): 545-51.
3. Bashein G, Townes BD, Nessly ML, et al. A randomized study of carbon dioxide management during hypothermic cardiopulmonary bypass. Anesthesiology. 1990; 72:7-15.
4. Hartman GS, Yao FSF, Bruefach M, et al. Severity of aortic atheromatous disease diagnosed by transesophageal echocardiography predicts stroke and other outcomes associated with coronary artery surgery: a prospective study. Anesth Analg 83:701-8.
5. Vermeyen KM, DeHert SG, Erpels FA, Adriaensen HF. Myocardial metabolism during anaesthesia with propofollow dose fentanyl for coronary artery bypass surgery. Brit J Anaesth. 1991; 66:504-8.
6. Thomson IR, Hudson RJ, Rosenbloom, Meatherall C. A randomized double-blind comparison of fentanyl and sufentanil anaesthesia for coronary artery surgery. Can J Anaesth. 1987; 34(3):227-32.
7. Sprigge JS, Wynands JE, Whalley DG, et al. Fentanyl infusion anesthesia for aortocoronary bypass surgery: plasma levels and hemodynamic response. Anesth Analg. 1982; 61(12):972-8.
8. Kono K, Philbin DM, Coggins CH, et al. Renal function and stress response during halothane or fentanyl anesthesia. Anesth Analg. 1981; 60(8):552-6.
9. Waller JL, Hug CC Jr, Nagle DM, Craver JM. Hemodynamic changes during fentanyl-oxygen anesthesia for aortocoronary bypass operation. Anesthesiology. 1981; 55(3):212-7.
10. Mora CT, Dudek C, Torjman MC, White PF. The effects of anesthetic technique on the hemodynamic response and recovery profile in coronary revascularization patients. Anesth Analg. 1995; 81(5):900-10.
11. Heikkila H, Jalonen J, Arola M, Kanto J, Laaksonen V. Midazolam as adjunct to high-dose fentanyl anesthesia for coronary artery bypass grafting operation. Acta Anaesthesiol Scand. 1984; 28(6):683-9.
12. McNulty SE, Gratch D, Kim JY. Comparative vascular effects of midazolam and lorezepam administered during cardiopulmonary bypass. Anesth Analg. 1994; 79:675-80.
13. Rogers AT, Stump DA, Gravlee GP, et al. Response of cerebral blood flow to phenylephrine infusion during hypothermic cardiopulmonary bypass: influence of PaCO2 management. Anesthesiology. 1988; 69:547-51.
14. Despotis GH, Filos KS, Zoys TN, Hogue CW Jr, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg. 1996; 82(1): 13-21.
15. Babka R, Colby C, El-Etr A, Pifarre R. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg. 1977; 73(5):780-2.
16. Kuitunen AH, Salmenpera MT, Heinonen J, Rasi VP, Myllyla G. Heparin rebound: a comparative study of protamine chloride and protamine sulfate in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anes. 1991; 5(3):221-6.
17. Pifarre R, Babka R, Sullivan HJ, Montoya A, Bakhos M, El-Etr A. Management of postoperative heparin rebound following cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981; 81:378-81.
18. Gravlee GP, Rogers AT, Dudas LM, et al. Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding. Anesthesiology. 1992; 76(3):393-401.
19. VA Cooperative Group. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration cooperative study. Circulation. 1988; 77:1324-32.
20. Torosian M, Michelson EL, Morganroth J, MacVaugh H 3d. Aspirin- and coumadin-related bleeding after coronaryartery bypass graft surgery. Ann Int Med. 1978; 89(3):325-8.
21. Pietraszek MH, Chabielska E, Buczko W. Effects of verapamil. diltiazem and nifedipine in some parameters of hemostasis in the rat. Thromb Res. 1988; 50:325-8.
22. Wagenknecht LE, Furberg CD, Hammon JW, Legault C, Troost BT. Surgical bleeding: unexpected effect of a calcium antagonist. Brit Med J. 1995;310:776-7.
23. Hines R, Barash PG. Infusion of sodium nitroprusside induces platelet dysfunction in vitro. Anesthesiology. 1989; 70(4):611-5.
24. Charlson ME, MacKenzie CR, Gold JP, Ales KL, Shires GT. Postoperative renal dysfunction can be predicted. Surg Gynecol Obstet. 1989; 169:303-9.
25. Charlson ME, MacKenzie CR, Gold JP, Shires GT. Postoperative changes in serum creatinine: when do they occur and how much is important? Ann Surg. 1989; 209(3):328-33.
26. Hilberman M, Derby GC, Spencer RJ, Stinson EB. Sequential pathophysiological changes characterizing the progression from renal dysfunction to acute renal failure following cardiac operation. J Thorac Cardiovasc Surg. 1980; 79(6):838-44.
27. Abel RM, Buckley MJ, Austen WG, et al. Etiology, incidence, and prognosis of renal failure following cardiac operations: results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg; 1976; 71(3):323-33.
28. Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation: prevalence. mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994; 107(6):1489-95.
29. Batiuk TD, Kurtz SB, Oh JK, Orszulak TA. Coronary aitery bypass operation in dialysis patients. Mayo Clin Proc. 1991; 66:45-53.
30. Heikkinen L, Harjula A, Merikallio E. Acute renal failure related to open-heart surgery. Ann Chir Gynaecol. 1985; 74(5): 203-209.